Mesa Laboratories Inc
NASDAQ:MLAB

Watchlist Manager
Mesa Laboratories Inc Logo
Mesa Laboratories Inc
NASDAQ:MLAB
Watchlist
Price: 97.96 USD 1.09% Market Closed
Market Cap: $540.7m

Mesa Laboratories Inc
Other Long-Term Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Mesa Laboratories Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Mesa Laboratories Inc
NASDAQ:MLAB
Other Long-Term Assets
$18.7m
CAGR 3-Years
18%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Boston Scientific Corp
NYSE:BSX
Other Long-Term Assets
$5.1B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
26%
Edwards Lifesciences Corp
NYSE:EW
Other Long-Term Assets
$1.9B
CAGR 3-Years
34%
CAGR 5-Years
40%
CAGR 10-Years
20%
Stryker Corp
NYSE:SYK
Other Long-Term Assets
$3.7B
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
12%
Abbott Laboratories
NYSE:ABT
Other Long-Term Assets
$18.4B
CAGR 3-Years
42%
CAGR 5-Years
38%
CAGR 10-Years
22%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Long-Term Assets
$1.7B
CAGR 3-Years
11%
CAGR 5-Years
16%
CAGR 10-Years
26%
No Stocks Found

Mesa Laboratories Inc
Glance View

Market Cap
540.7m USD
Industry
Health Care

Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 506 full-time employees. The firm operates through four segments, Sterilization and Disinfection Control, Biopharmaceutical Development, Instruments, and Continuous Monitoring. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators which are used to assess the effectiveness of sterilization and disinfection processes in the hospital, medical device, and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Instruments segment designs, manufactures, and markets quality control hardware and disposable products. The Continuous Monitoring segment develops, and markets systems which are used to monitor various environmental parameters such as temperature, humidity, and differential pressure.

MLAB Intrinsic Value
86.74 USD
Overvaluation 11%
Intrinsic Value
Price $97.96

See Also

What is Mesa Laboratories Inc's Other Long-Term Assets?
Other Long-Term Assets
18.7m USD

Based on the financial report for Dec 31, 2025, Mesa Laboratories Inc's Other Long-Term Assets amounts to 18.7m USD.

What is Mesa Laboratories Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
1%

Over the last year, the Other Long-Term Assets growth was -4%. The average annual Other Long-Term Assets growth rates for Mesa Laboratories Inc have been 18% over the past three years , 1% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett